Multiple sclerosis in Finland: Incidence trends and differences in relapsing remitting and primary progressive disease courses

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 1, 2003, Pages 25-28

  Sumelahti, M L ^a   Tienari, P J ^b   Hakama, M ^a   Wikstrom J ^b  

^a UNIVERSITY OF TAMPERE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; ENVIRONMENTAL FACTOR; FEMALE; FINLAND; GEOGRAPHIC DISTRIBUTION; GROWTH; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE;

ADOLESCENT; ADULT; AGED; CHILD; DEMOGRAPHY; DISEASE PROGRESSION; FEMALE; FINLAND; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 0037224679     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.1.25     Document Type: Article

References (37)

1. Charcot JM. Lectures on the Disease of the Nervous System. Translated by Sigerson G. London: The New Sydenham Society, 1877:157-222.
2. McAlpine D, Compston ND, Lumsden CE. Multiple Sclerosis. Edinburgh: Livingstone, 1955.
3. Confavreax C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980;103:281-300.
4. Minderhoud J, van der Hoeven J, Prange A. Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study. Acta Neurol Scand 1988;78:10-15.
5. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: A geographicarly based study. I. Clinical course and disability. Brain 1989;112:133-46.
6. Thompson A, Polman C, Miller D, et al. Primary progressive multiple sclerosis. Brain 1997;120:1085-96.
7. Phadke J. Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis. Brain 1990;113:1597-628.
8. Thompson A, Kermode A, MacManus D, et al. Patterns of disease activity in multiple sclerosis: Clinical and magnetic resonance study. BMJ 1990;300:631-4.
9. Revesz T, Kidd D, Thompson A, et al. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 1994;117:759-65.
10. Olerup O, Hillert J, Fredrikson S, et al. Primarily chronic progressive and relapsing/remitting multiple sclerosis: Two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 1989;86:7113-17.
11. Masterman T, Ligers A, Olsson T, et al. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 2000;48:211-19.
12. Weatherby S, Thomson W, Pepper L, et al. HLA-DRB1 and disease outcome in multiple sclerosis. J Neurol 2001;248:304-10.
13. Kurtzke J. Geography in multiple sclerosis. J Neurol 1977;215:1-26.
14. Rinne U, Panelius M, Kivalo E, et al. Distribution of multiple sclerosis in Finland with special reference to some geological factors. Acta Neurol Scand 1966;42:385-99.
15. Wikström J, Palo J. Studies on the clustering of multiple sclerosis in Finland. I. Comparison between the domiciles and places of birth in selected subpopulations. Acta Neurol Scand 1975;51:85-98.
16. Kinnunen E, Wikström J, Porras J, et al. The epidemiology of multiple sclerosis in Finland: Increase of prevalence and stability of foci in high-risk areas. Acta Neurol Scand 1983;67:255-62.
17. Sumelahti M-L, Tienari P, Wikström J, et al. Regional and temporal variation in the incidence of multiple sclerosis in Finland in 1979-1993. Neuroepidemiology 2000;19:67-75.
18. Sumelahti M-L, Tienari P, Wikström J, et al. Increasing prevalence of multiple sclerosis in Finland. Acta Neurol Scand 2001;103:1-6.
19. Wikström J. Studies on clustering of multiple sclerosis in Finland. II. Microepidemiology in one high-risk county with special reference to familial cases. Acta Neurol Scand 1975;51:173-83.
20. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983;13:227-31.
21. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology 1996;46:907-11.
22. Kremenchutzky M, Cottrell D, Rice G, et al. The natural history of multiple sclerosis: A geographically based study 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: A re-evaluation. Brain 1999; 122:1941-9.
23. Noseworthy J, Paty D, Wonnacot T, et al. Multiple sclerosis after age 50. Neurology 1983;33:1537-44.
24. Armitage P, Berry G. Standardization. In: Armitage P, Berry G, eds. Statistical methods in medical research. Cambridge: Blackwell Science, 1994:436-43.
25. Robertson N, Compston DAS. Surveying multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1995;58:2-6.
26. Warren S, Warren K. Prevalence, incidence and characteristics of multiple sclerosis in Westlock County, Alberta, Canada. Neurology 1993;43:1760-963.
27. Nevanlinna HR. Genetic markers in Finland. Haematologia 1980;13:65-74.
28. de la Chapelle A. Disease gene mapping in isolated human populations: The example of Finland. J Med Genet 1993;30:857-65.
29. Sirén M, Sareneva H, Lokki M, et al. Unique HLA antigen frequencies in the Finnish population. Tissue Antigens 1996;48:703-7.
30. Khurram B, Whitaker N. Clinical and laboratory features of primary progressive and secondary progressive MS. Neurology 1999;53:765-71.
31. McDonnell G, Hawkins S. Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK. J Neurol Neurosurg Psychiatry 1998;64:451-4.
32. Larsen J, Kvale G, Riise T, et al. Multiple sclerosis - More than one disease. Acta Neurol Scand 1985;72:145-50.
33. Larsen JP, Aarli H, Nyland H, et al. Western Norway, a high-risk area for multiple sclerosis: A prevalence/incidence study in the county of Hardaland. Neurology 1984;34:1202-7.
34. Grønning M, Riise T, Kvale G, et al. Incidence of multiple sclerosis in Hordaland, Western Norway: A fluctuating pattern. Neuroepidemiology 1991;10:53-61.
35. Kinnunen E, Koskimies S, Lagerstedt A, et al. Histocompatibility antigens in familial multiple sclerosis in a high-risk area of the disease. J Neurol Sci 1984; 65:147-55.
36. Tienari PJ, Wikström J, Sajantila A, et al. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet 1992; 340:987-91.
37. Challoner P, Smith K, Porker J, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995; 92:7440-4.